SCHEMBL8008005

SCHEMBL8008005

N#CNCC(c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.45
GRIN2A Q12879 2/20 0.45
TSHR P16473 2/20 0.41
TRPA1 O75762 1/20 0.41
HTR2A P28223 4/20 0.41
TAAR1 Q96RJ0 2/20 0.41
KDM4E B2RXH2 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HRH1 P35367 4/20 0.39
MTOR P42345 1/20 0.38
RAB9A P51151 1/20 0.38
GRM7 Q14831 1/20 0.38
AOC3 Q16853 4/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX15 P16050 1/20 0.37
KDM1A O60341 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6104432 0.77 GRIN1 (0.45) GRIN1GRIN2ATSHRHTR2ATAAR1
Water SCHEMBL28973052 0.70 MTOR (0.62) GRIN1GRIN2ATSHRHTR2ATAAR1
SCHEMBL1908636 0.69 TAAR1 (0.64) GRIN1GRIN2AHTR2ATAAR1KDM4E
SCHEMBL3952853 0.69 PBRM1 (0.47) TSHRTRPA1HTR2ATAAR1KDM4E
Water SCHEMBL5164513 0.69 PBRM1 (0.47) TSHRTRPA1HTR2ATAAR1KDM4E
SCHEMBL27366623 0.69 AOC3 (0.64) GRIN1GRIN2AHTR2ATAAR1KDM4E
SCHEMBL3449112 0.67 MTOR (0.46) TSHRTRPA1KDM4EL3MBTL1MTOR
SCHEMBL581278 0.67 MAPT (0.52) TSHRKDM4EMEN1KMT2ACYP3A4
SCHEMBL2308839 0.67 MAPT (0.52) GRIN1GRIN2AHTR2ATAAR1KDM4E
SCHEMBL9778091 0.67 TSHR (0.44) TSHRTRPA1HTR2ATAAR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6060484-A Anti-viral method ELI LILLY AND COMPANY (US) 2000-05-09 US disclosed
EP-0806205-A2 Urea, thiourea and guanidine compounds and their use as anti-viral agents ELI LILLY AND COMPANY (US) 1997-11-12 EP disclosed